APROGEN MEDICINES INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,579 KRW | +6.33% |
|
+8.75% | +64.48% |
| Sales 2022 | 78.35B 56.88M 4.75B | Sales 2023 | 151B 109M 9.13B | Capitalization | 234B 170M 14.2B |
|---|---|---|---|---|---|
| Net income 2022 | -98.66B -71.62M -5.98B | Net income 2023 | -55.62B -40.38M -3.37B | EV / Sales 2022 | 5.65 x |
| Net Debt 2022 | 42.74B 31.03M 2.59B | Net Debt 2023 | 83.73B 60.79M 5.08B | EV / Sales 2023 | 2.11 x |
| P/E ratio 2022 |
-3.45
x | P/E ratio 2023 |
-4.07
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 41.81% |
More Fundamentals
* Assessed data
More news
| 1 day | +6.33% | ||
| 1 week | +8.75% | ||
| Current month | +15.34% | ||
| 1 month | +15.34% | ||
| 3 months | +73.52% | ||
| 6 months | +66.21% | ||
| Current year | +64.48% |
1 week
1 436.00
1 636.00
1 month
1 353.001 891.00
Current year
701.001 894.00
1 year
701.003 185.00
3 years
561.008 610.00
5 years
561.0014 370.00
10 years
561.0058 350.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jae-Sup Kim
CEO | Chief Executive Officer | 61 | - |
Hak-Ju Kim
AUD | Comptroller/Controller/Auditor | 67 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jae-Sup Kim
CEO | Chief Executive Officer | 61 | - |
Hyun-Soo Lee
BRD | Director/Board Member | 68 | - |
Jung-Chool Kim
BRD | Director/Board Member | 68 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 1,579 | +6.33% | 16,980,110 |
| 29/24/29 | 1,485 | +0.54% | 2,540,246 |
| 26/24/26 | 1,477 | -1.86% | 5,588,430 |
| 25/24/25 | 1,505 | -6.17% | 6,072,688 |
| 24/24/24 | 1,604 | +9.12% | 10,633,800 |
End-of-day quote Korea S.E., April 30, 2024
More quotes
Aprogen Inc, formerly Aprogen Medicines Inc, is a Korea-based company mainly engaged in the business of hardfacing. The Company operates its business through six segments. The Hardfacing segment is engaged in the provision of hardfacing for maintenance of steel mills, thermal power plants and cement plants. The Steel Sale segment is engaged in the sale of steel products, aluminum ingots and others. The Insulation segment is engaged in the nuclear thermal insulation and insulation construction. The Pharmaceutical segment is engaged in the manufacture and sale of pharmaceuticals. The Game segment is engaged in the mobile game publishing business. The Other segment is engaged in the sale of scrap metal.
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +64.48% | 278M | |
| +0.86% | 12.49B | |
| +16.89% | 6.4B | |
| +1.79% | 3.06B | |
| -7.95% | 1.69B | |
| -9.63% | 980M | |
| -41.64% | 764M | |
| -34.52% | 628M | |
| -3.86% | 623M | |
| +8.78% | 581M |
- Stock Market
- Equities
- A007460 Stock
